Alhumaidi M, et al. (2022) Residues forming the gating regions of asymmetric multidrug transporter Pdr5 also play roles in conformational switching and protein folding. J Biol Chem 298(12):102689 PMID:36370844
Wagner M, et al. (2022) A New Twist in ABC Transporter Mediated Multidrug Resistance - Pdr5 is a Drug/proton Co-transporter. J Mol Biol 434(14):167669 PMID:35671830
Arya N, et al. (2019) An A666G mutation in transmembrane helix 5 of the yeast multidrug transporter Pdr5 increases drug efflux by enhancing cooperativity between transport sites. Mol Microbiol 112(4):1131-1144 PMID:31294884
Sachs J, et al. (2019) Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. Front Pharmacol 10:400 PMID:31040786
Tanabe K, et al. (2019) FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops. Antimicrob Agents Chemother 63(1) PMID:30348662
Gupta RP, et al. (2014) New examples of membrane protein expression and purification using the yeast based Pdr1-3 expression strategy. J Biotechnol 191:158-64 PMID:25036752
Infed N, et al. (2013) Analysis of the inhibition potential of zosuquidar derivatives on selected bacterial and fungal ABC transporters. Mol Membr Biol 30(2):217-27 PMID:23356389
Kueppers P, et al. (2013) Functional impact of a single mutation within the transmembrane domain of the multidrug ABC transporter Pdr5. Biochemistry 52(13):2184-95 PMID:23464591
Ernst R, et al. (2008) A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc Natl Acad Sci U S A 105(13):5069-74 PMID:18356296